文献速递免疫规划卫生政策与健康促进

韩国水痘与带状疱疹疫苗接种的流行病学及经济学影响:一项数学建模研究

The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.
PubMed 文献 · Vaccine · 2024-05-18

韩国自2005年起为1岁儿童纳入单剂水痘疫苗。本研究用年龄结构模型模拟50年内引入2剂水痘疫苗(4岁,覆盖率90%)联合带状疱疹疫苗(60岁,覆盖率60%,含最初5年补种)的流行病学与经济学影响。结果显示所有策略均具成本效果并大幅减少带状疱疹发病;重组带状疱疹疫苗(RZV)比减毒活疫苗(ZVL)预防更多病例和QALY增益,但ZVL在较低支付意愿下更具成本效果。

要点

  • RZV预防的带状疱疹病例数为ZVL的两倍且QALY增益更大,但ZVL成本更低更具成本效果。

核心结论

  • RZV联合2剂水痘疫苗策略更有效减少疾病负担并改善QALY,但ZVL在较低支付意愿水平下更具成本效果。
  • 疫苗接种政策决策应平衡公共卫生需求与支付意愿水平。

研究设计与样本

  • 采用年龄结构数学模型,模拟50年时间跨度,假设带状疱疹疫苗在最初5年开展补种活动。
  • 基础情景考虑四种策略,包括为60岁人群接种带状疱疹疫苗(覆盖率60%),以及联合为4岁儿童接种第二剂水痘疫苗(覆盖率90%)。

主要发现

  • 所有策略均具成本效果,并显著降低带状疱疹发病率,根据所选策略不同,可预防约3077000至7609000例带状疱疹。
  • 联合策略额外预防约4950000例水痘和653000例带状疱疹。
  • RZV在预防带状疱疹病例数上是ZVL的两倍,并提供更大的QALY增益。
  • ZVL因其较低成本而更具成本效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In South Korea, the National Immunization Program has included one-dose varicella vaccination for 1-year-olds since 2005. This study examines the potential impact of introducing a two-dose varicella vaccination for children, along with zoster vaccination for adults, using either the zoster vaccine live (ZVL) or recombinant zoster vaccine (RZV). METHODS: The investigation considered four strategies in a base case scenario. The first involved introducing zoster vaccination for 60-year-olds, with a 60 % coverage. The second strategy combined zoster vaccination with a second-dose varicella vaccination for 4-year-olds, with a 90 % coverage. An age-structured model spanning 50 years was employed, assuming a zoster vaccine catch-up campaign over the initial 5 years. Cost-effectiveness analyses were conducted, assessing incremental cost-effectiveness ratios (ICERs), incremental net monetary benefits (INMBs), and net loss under different ages at zoster vaccination (50, 60, 65, and 70 years) and varying willingness-to-pay (WTP) levels from ₩40 million ($34,998) to ₩84 million ($74,000). RESULTS: All strategies were cost-effective and significantly reduced herpes zoster (HZ) incidence, preventing approximately 3,077,000 to 7,609,000 cases, depending on the chosen strategy. The combined strategy prevented around 4,950,000 varicella and 653,000 HZ cases additionally. RZV outperformed ZVL by preventing twice as many HZ cases and offering greater QALY gains. However, ZVL was more cost-effective due to its lower cost. Probabilistic sensitivity analyses revealed that RZV became more cost-effective at higher WTP thresholds, exceeding ₩60.9 million ($53,193) in terms of ICER and ₩62.5 million ($54,591) for INMBs and net loss. The optimal age for zoster vaccination was 60 years concerning ICER but 50 years regarding INMB. CONCLUSIONS: Combining RZV with a two-dose varicella vaccination strategy reduced the disease burden and improved QALY more effectively, though ZVL remained more cost-effective at lower WTP levels. Decisions regarding vaccination policies should be balanced between the public health needs and WTP levels.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim S, Choi JK, Suh J, et al. The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study. Vaccine. 2024. PMID: 38762358. doi:10.1016/j.vaccine.2024.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。